DOCSLIB.ORG

Holding & Investment Companies Overview

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

HOLDING & INVESTMENT COMPANIES OVERVIEW May 22nd 2013 Jan-Willem Billiet +32 2 429 45 04 [email protected] Tom Simonts +32 2 429 37 22 [email protected] Table of contents Financial calendars ................................................................................................................................................. 3 Valuation matrix & Recommendation overview .............................................................................................. 4 Dividend data ............................................................................................................................................................ 5 Valuation graphs ...................................................................................................................................................... 6 Average holding discount ..................................................................................................................................... 7 Sector performance ................................................................................................................................................ 8 Track record .............................................................................................................................................................. 9 Favourite list .............................................................................................................................................................. 10 Cascade structures and traditional holdings • The Albert Frère structure ............................................................................................................................ 11 - GBL .......................................................................................................................................................... 12 - Pargesa ................................................................................................................................................... 17 • The UCB structure ......................................................................................................................................... 22 - Tubize ...................................................................................................................................................... 23 • The Solvay structure ..................................................................................................................................... 27 - Solvac ....................................................................................................................................................... 28 • The KBC structure ......................................................................................................................................... 32 - KBC Ancora ............................................................................................................................................ 33 • The Boël structure ......................................................................................................................................... 37 - Henex ...................................................................................................................................................... 38 - Sofina ...................................................................................................................................................... 43 • Brederode ....................................................................................................................................................... 48 • Heineken holding ........................................................................................................................................... 53 Private Equity & Privak companies • Gimv ................................................................................................................................................................ 58 • Quest for Growth ........................................................................................................................................... 63 Diversified holding companies • Ackermans & van Haaren ............................................................................................................................. 69 • BIP Investment Partners ............................................................................................................................... 75 • Bois Sauvage ................................................................................................................................................. 80 • HAL Trust.......................................................................................................................................................... 85 • Luxempart ....................................................................................................................................................... 90 • Punch International ........................................................................................................................................ 95 • RHJ International ........................................................................................................................................... 100 p. 2 Financial calendars Financial calendar Recent news flow Company Event Date Company Title 8-May-13 Brederode General Assembly 17 May HAL Trust Soft optical retail figures 8-May-13 GBL Trading update 1Q 16 May Sofina Playing the online retail card again 8-May-13 Pargesa Holding General Assembly 15 May Gimv When flirting ends betw een the sheets 8-May-13 Pargesa Holding Results 1Q 15 May Ackermans A comforting trading update 10-May-13 BIP General Assembly 14 May Henex Buyback doesn't prelude delisting (yet?) 10-May-13 Bois Sauvage Trading update 1Q 14 May GBL Ready to shoot an elephant 10-May-13 Solvac Trading update 1Q 14 May Bois Sauvage The chocolate take-over 15-May-13 Ackermans Trading update 1Q 14 May Punch International 1Q13 update brings no new s on Xeikon bid 16-May-13 Hal Trust General Assembly 10 May Pargesa 1Q13 brings no changes to portfolio; DPS confirmed 16-May-13 Hal Trust Trading update 1Q 09 May GBL 1Q13 cash earnings in line; no change to portfolio 17-May-13 Luxempart Trading update 1Q 06 May Brederode 1Q13 update brings no additional info 17-May-13 Moury Construct Trading update 1Q 06 May Quest for Grow th End of April NAV -0.2% 17-May-13 Punch International Trading update 1Q 02 May Ackermans Paddling through 17-May-13 Sapec Trading update 1Q 26 Apr Quest for Grow th Houston, w e (might) have a dividend 23-May-13 Gimv Results FY 24 Apr Heineken Holding 1Q13 update: dow ngrade to Hold & TP lowered 23-May-13 Gimv Analyst Meeting 19 Apr Sofina Feedback analyst meeting 23-May-13 Punch International General Assembly 03 Apr Henex FY12 current result +4.8%; DPS +6.1% 27-May-13 Ackermans General Assembly 03 Apr Sofina FY12 net result +9%; DPS +5.4%; Rating low ered 5-Jun-13 Gimv Roadshow 02 Apr Luxempart DPS +10%; Possible additional Pescanova impact 10-Jun-13 Gimv Roadshow 28 Mar HAL Trust Solid set of Optical Retail figures 20-Jun-13 Gimv Roadshow 26 Mar Tubize FY12 results in line;poison-pill cancelled; upped TP 26-Jun-13 Gimv General Assembly 26 Mar Gimv Selling Halder stake to Halder partners 16-Jul-13 BIP Results 1H 19 Mar Gimv Eyeballing Lampiris 18-Jul-13 Gimv Results 1Q 15 Mar Pargesa BNP launched €250m bond convertible into Pargesa 25-Jul-13 Quest for Grow th Results 1H 12 Mar HAL Trust Additional $27m payment to SBM Offshore 30-Jul-13 Pargesa Holding Results 1H 11 Mar Brederode FY12 DPS +3.4%; Vibrant activity in PE 21-Aug-13 Heineken Holding Results 1H 11 Mar Gimv Exit Astex and low ered Ablynx stake 23-Aug-13 Punch International Results 1H 07 Mar Quest for Grow th End-of-February NAV rises 2% 28-Aug-13 Ackermans Results 1H 06 Mar BIP Whopping 20% increase in DPS; TP lowered to €61 28-Aug-13 Hal Trust Results 1H 29-Aug-13 Sapec Results 1H 06 Mar Pargesa FY12 economic earnings +4.7%; Flat DPS 29-Aug-13 Sofina Results 1H 06 Mar GBL Underlying cash earnings in line; DPS +1.9% 30-Aug-13 Brederode Results 1H 05 Mar Bois Sauvage FY12 DPS increases 2.9% 30-Aug-13 Luxempart Results 1H 04 Mar Solvac Flat FY12 Solvac dividend 30-Aug-13 Vranken-Pommery Results 1H 28 Feb Tubize TP upped from €45 to €49 31-Aug-13 Solvac Results 1H 28 Feb Gimv €50m commitment to new healthcare fund 19-Oct-13 BIP Results 3Q 28 Feb Ackermans Current FY12 earnings -6%; DPS +2% 23-Oct-13 Heineken Holding Results 3Q 27 Feb Punch International Solid Xeikon results; no new s on bid 24-Oct-13 Quest for Grow th Results 3Q 27 Feb Ackermans FY12 preview 25-Oct-13 Brederode Trading update 1Q 26 Feb Gimv VPG bankruptcy filing flanks €200m healthcare fund 7-Nov-13 Pargesa Holding Results 3Q 22 Feb Gimv Thin discount but a fat yield 9-Nov-13 Punch International Results 3Q 21 Feb Gimv 3Q12/13 NAV rises 1% to €40.93 12-Nov-13 Solvac Trading update 3Q 13 Feb Heineken Holding FY12 net result +106%; confirms DPS policy 14-Nov-13 Hal Trust Trading update 3Q 11 Feb Solvac TP upped from €120 to €135 15-Nov-13 Ackermans Trading update 3Q 11 Feb Gimv Multiplicom raises €5.5m in capital round 15-Nov-13 Sapec Trading update 3Q 01 Feb Luxempart Bertelsmann considers reducing RTL stake 21-Nov-13 Gimv Results 1H 01 Feb BIP Bertelsmann considers reducing RTL stake 21-Nov-13 Gimv Analyst Meeting 29 Jan Punch International Dumarey ups stake from 11.5% to 15.1% 21-Nov-13 Luxempart Trading update
Recommended publications
  • Euro Stoxx® Multi Premia Index

    Euro Stoxx® Multi Premia Index

    EURO STOXX® MULTI PREMIA INDEX Components1 Company Supersector Country Weight (%) SARTORIUS STEDIM BIOTECH Health Care France 1.59 IMCD Chemicals Netherlands 1.25 VOPAK Industrial Goods & Services Netherlands 1.15 BIOMERIEUX Health Care France 1.04 REMY COINTREAU Food, Beverage & Tobacco France 1.03 EURONEXT Financial Services France 1.00 HERMES INTERNATIONAL Consumer Products & Services France 0.94 SUEZ ENVIRONNEMENT Utilities France 0.94 BRENNTAG Chemicals Germany 0.93 ENAGAS Energy Spain 0.90 ILIAD Telecommunications France 0.89 DEUTSCHE POST Industrial Goods & Services Germany 0.88 FUCHS PETROLUB PREF Chemicals Germany 0.88 SEB Consumer Products & Services France 0.87 SIGNIFY Construction & Materials Netherlands 0.86 CARL ZEISS MEDITEC Health Care Germany 0.80 SOFINA Financial Services Belgium 0.80 EUROFINS SCIENTIFIC Health Care France 0.80 RATIONAL Industrial Goods & Services Germany 0.80 AALBERTS Industrial Goods & Services Netherlands 0.74 KINGSPAN GRP Construction & Materials Ireland 0.73 GERRESHEIMER Health Care Germany 0.72 GLANBIA Food, Beverage & Tobacco Ireland 0.71 PUBLICIS GRP Media France 0.70 UNITED INTERNET Technology Germany 0.70 L'OREAL Consumer Products & Services France 0.70 KPN Telecommunications Netherlands 0.68 SARTORIUS PREF. Health Care Germany 0.68 BMW Automobiles & Parts Germany 0.68 VISCOFAN Food, Beverage & Tobacco Spain 0.67 SAINT GOBAIN Construction & Materials France 0.67 CORBION Food, Beverage & Tobacco Netherlands 0.66 DAIMLER Automobiles & Parts Germany 0.66 PROSIEBENSAT.1 MEDIA Media Germany 0.65
  • Press Release

    Press Release

    Press release Luxembourg, 4 July 2011 INTERIM REVISION OF THE LUXX INDEX Following the end of the first half of 2011, there was no change to the companies that are included in the LuxX index of the Luxembourg Stock Exchange. However, an adjustment was made in the weighting of the companies making up the index, based on their closing prices, the number of shares outstanding and their free-float. Therefore, on Friday 1 July 2011, the index had the following configuration: Weighting Number Weighting Number Company at 30/06/2011 of shares at 1/03/2011 of shares Aperam 11.13% 210 14.33% 210 ArcelorMittal 19.62% 345 20.00% 345 BIP Investment Partners 2.21% 15 2.09% 15 Dexia 1.85% 364 2.62% 364 Foyer 0.80% 7 0.70% 7 KBC Group 7.07% 110 7.42% 110 Luxempart 3.19% 56 2.98% 56 Reinet Investments 17.23% 581 15.43% 581 RTL Group 10.95% 68 11.02% 68 SES 22.32% 490 20.00% 490 Socfinaf 2.27% 40* 1.83% 4 Socfinasia 1.36% 20* 1.59% 1 (* split at 01-07-2011) About the Luxembourg Stock Exchange The Luxembourg Stock Exchange began operating as a limited company in 1929, and has since gained extensive experience in listing and trading of securities from many different regions. Today the Luxembourg Stock Exchange has two markets — regulated and Euro MTF — with 29,694 international bond issues representing 42% of total international bonds listed on EU markets. It also lists some 6,440 shares and units of investment funds in around twenty currencies, offering a wide range of investment opportunities, as well as 264 depositary receipts of issuers based in emerging markets.
  • Annual Report 2019

    Annual Report 2019

    ANNUAL REPORT 2019 ANNUAL REPORT 2019 CONTENTS Annual report 2019 Management report on consolidated accounts p. 6 Corporate Governance p. 29 Annual remuneration report p. 53 Information on Corporate Social Responsibility (CSR) p. 57 Operational Group Chart p. 58 Our main investment lines p. 60 Fund of Funds: our main lines p. 78 Financial information IFRS consolidated Financial statements p. 84 Annual accounts and report of the réviseur d’entreprises agrée p. 134 Contents 5 2019 MANAGEMENT REPORT ON THE SOCIAL AND CONSOLIDATED FINANCIAL STATEMENTS as at 31 December 2019 OUR DNA Luxempart is a Luxembourg based investment holding › Investments are realized along the following company with more than 25 years of existence, an estimated guidelines net asset value of 1.58 € billion and a market capitalisation • investment amounts up to € 100 million of nearly 1.1 € billion as of end of 2019. • investment in listed and non-listed companies • no exit pressure Luxempart invests in several European countries, mainly • involvement on board level in the DACH region (Germany, Austria and Switzerland), • supportive, hands-on approach Luxembourg, Belgium and France. Its core team is based • no sector focus but affinity for energy, insurance, tele- in Luxembourg. communication, security, health care and education Luxempart also holds a fund of funds portfolio through Luxempart shareholders and management believe in investments in selected European funds. It is a sponsor of value creation through patient involvement, European several closely associated funds in Italy, France and Ger- mind-set and ambitious team spirit. many. Luxempart will develop, next to its direct investment activity, its fund exposure to additional geographies and Our evolution has been characterized by a successful di- strengthen its fund team.
  • Purpose & Patience

    Purpose & Patience

    PURPOSE & PATIENCE We aspire to be the preferred partner of entrepreneurs and families who lead growing companies by backing them with patient capital and supportive advice — Q1 2020 Edition — OUR MISSION Our goal at Sofina is to create economic value with a human approach We believe that the entrepreneurial spirit that characterises many family businesses and growth companies is a source of progress. By supporting these entrepreneurs and innovators, we intend to contribute to global growth, development and innovation. We believe entrepreneurs become successful by being competitive in a globalised market Our mission is to provide patient capital, expertise and advice to growing companies led by entrepreneurs and families. We aspire to be their preferred partner, and have a long-term horizon that few other investors can match. Our heritage and culture are what make us unique We put human relationships at the heart of what we do. All our investments are stories of shared values, friendships and ambitious projects with talented entrepreneurs and their management teams. By continuously working in this way, we aspire to become the preferred investment partner of those sharing our beliefs and vision. 2 SOFINA - PURPOSE & PATIENCE OUR MISSION 3 KEY FIGURES Highlights EUR 7.63 BN GLOBAL SHAREHOLDERS’ EQUITY REACH A FAMILY RUN 3 US EUROPE ASIA AND CONTROLLED COMPLEMENTARY Change over the last 20 INVESTMENT COMPANY INVESTMENT years (2) STYLES 8.00 7.00 6.00 5.00 FOUR FOCUS 4.00 SECTORS Long-term minority 3.00 investments 2.00 1.00 43% OF SHAREHOLDERS’ EQUITY (1) Offices in Brussels, 0 Luxembourg and Singapore Consumer and Retail 1999 2019 Sofina Private Funds – Investments in venture and growth capital funds Digital Transformation 31% OF SHAREHOLDERS’ EQUITY (1) Roots going back 26 Sofina Growth – Investments in Education investment fast-growing businesses professionals 120+ YEARS across our 20% OF SHAREHOLDERS’ EQUITY (1) 3 offices Healthcare (1) Considering the portfolio in transparency.
  • Luxx Price Index

    Luxx Price Index

    LuxX Price and return BASIS 1,000 AS OF 4TH JANUARY 1999 2021 The LuxX Index The LuxX Index is a basket index with a twofold computation, ie the Price LuxX Index and the Return LuxX Index. The Price index is published as of 4 January 1999. The Return LuxX Index is similar to the Price index except that it takes into account the stripped net dividends. In so doing, it enables the investors to assess their return on investment. The Return index has been published since 31 March 1999. 1. INDEX ENTRY REQUIREMENTS 3. THE LUXX INDEX IS A BASKET INDEX a) all shares issued by Luxembourg companies listed on the The LuxX Index relies on a basket of easily tradable securities Luxembourg Stock Exchange having directly or indirectly meeting the requirements defined above. an economic activity in Luxembourg, a significant activity on the Luxembourg Stock Exchange market or whose part The number of securities included in the basket for a given of the shareholders is Luxembourg-based are eligible. share is obtained by applying its weight to the basis The Executive Committee decides on the eligibility capitalisation of the index basket. The resulting amount in respect of each company by assessing whether one is then divided by the last stock exchange price of the month of these requirements are adequately met; preceding the index update date. b) the LuxX Index is an open index, which means that the number of eligible constituent companies is not limited. 4. REVISION OF THE INDEX CONSTITUENTS As a matter of fact, any company meeting the requirements specified in paragraph above can be retained among A revision of the LuxX Index constituents is made annually the index constituents.
  • Other Financial Services Investment Research Sector Update

    Other Financial Services Investment Research Sector Update

    Other Financial Services Investment Research Sector Update 01 March 2011 -40% 170 -35% 160 BELGIAN HOLDING AND INVESTMENT COMPANIES -30% 150 -25% 140 Last month's news flow Ackermans & van Haaren Bank Van Breda intends to launch a counter bid on ABK -20% 130 Ackermans & van Haaren Publication of flash note "FY10 preview: considerable increase of current result expected" -15% 120 Bois Sauvage Final closing of the sale of its participation in Bank Degroof -10% 110 Bois Sauvage Simplification of controlling structure - upgrade to Buy CNP/NPM Interruption of share buy-back programme -5% 100 CNP/NPM CNP/NPM portfolio company BIG is not to be sold 0% 90 Gimv Folow-up investment in NovoPolymers 90 92 94 96 98 00 02 04 06 08 10 12 Gimv 9M10/11 update Source : Bloomberg, ESN - Bank Degroof Research Gimv Divestment of Plexxikon to Daiichi Sankyo Histogram : Average (unweighted) discount to adjusted NAV of 5 largest Quest for Growth Publication of company update "FY10 release and portfolio update" holding companies (LHS) RHJ International Publication of flash note "The final settlement of the Honsel bankruptcy could turn out Line : Cumulative excess return Belgian investment companies vs. Belgian to be more favourable for RHJI than previously anticipated" All Shares Return Index since 1990 (RHS) RHJ International Refinancing of Asahi Tec's debt RHJ International Sale of stake in Niles Sector performances Abs. Perf. (1 month) -0.8% Financial calendar Abs. Perf. (3 month) 6.7% 03-Mar-11 Ackermans & van Haaren FY10 Results + analyst meeting 03-Mar-11
  • Fact Sheet As of 06/30/2021

    Fact Sheet As of 06/30/2021

    iShares MSCI Belgium ETF EWK Fact Sheet as of 06/30/2021 The iShares MSCI Belgium ETF seeks to track the investment results of a broad-based index composed of Belgian equities. KEY FACTS Fund Launch Date 03/12/1996 Expense Ratio 0.51% WHY EWK? Benchmark MSCI Belgium IMI 25/50 1 Exposure to a broad range of companies in Belgium Index 2 Targeted access to Belgian stocks 30 Day SEC Yield 1.26% Number of Holdings 45 3 Use to express a single country view Net Assets $42,175,764 Ticker EWK GROWTH OF 10,000 USD SINCE INCEPTION CUSIP 464286301 Exchange NYSE Arca TOP HOLDINGS (%) ANHEUSER BUSCH INBEV SA 21.73 KBC GROEP 9.11 ARGENX 6.71 UCB SA 6.40 GROUPE BRUXELLES LAMBERT NV 4.60 UMICORE SA 4.56 SOLVAY SA 4.25 Fund Benchmark AGEAS SA 3.94 The Growth of $10,000 chart reflects a hypothetical $10,000 investment and assumes SOFINA SA 3.36 reinvestment of dividends and capital gains. Fund expenses, including management fees and WAREHOUSES DE PAUW NV 2.63 other expenses were deducted. 67.29 PERFORMANCE Holdings are subject to change. 1 Year 3 Year 5 Year 10 Year Since Inception NAV 35.40% 5.77% 7.10% 7.56% 5.81% Market Price 35.81% 6.06% 7.06% 7.57% 5.82% Benchmark 29.34% 4.17% 6.10% 7.91% 5.85% The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than the original cost.
  • Company Profile

    Company Profile

    COMPANY PROFILE - October 2015 - GENERAL OVERVIEW MISSION & VALUES Sofina is a European, family-controlled, investment Our Mission company listed on Euronext Brussels. To provide patient and supportive Market Capitalization* : € 3.4 Bn capital helping families and entrepreneurs to develop their Net Asset Value* : € 4.9 Bn businesses Offices in Brussels, Luxemburg & Singapore Our Values A team of 51 professionals across our offices Entrepreneurial talent and families are a major driver of progress and Website: www.sofina.be innovation globally. Sofina’s mission (* Jun 2015, excl. own shares) is… … to foster the long-term growth of 3 MAIN LINES OF BUSINESS their endeavors … to provide, directly or indirectly, with 1. Long term strategic minority investments (~65%) patient capital and value-added support tailored to their specific needs 2. Investments in top tier Private Equity Funds (~25%) … to become the preferred partner of every like-minded family or 3. Co-investments in fast growing businesses (<10%) entrepreneur in the investment business 1 I. LONG TERM STRATEGIC INVESTMENTS INVESTMENT PHILOSOPHY MAIN HOLDINGS Minority investor (€ 75-200 M equity tickets) Long term view Active and supportive Board participation Public or private corporations Diversified sector base Primarily European based companies 2 II. ALTERNATIVE INVESTMENTS - PRIVATE EQUITY/VENTURE CAPITAL FUNDS INVESTMENT PHILOSOPHY MAIN PARTNERS USA (70%) Long-term partnerships with leading funds Focus on Venture and Expansion Capital Predominantly US-based EMERGING MARKETS (15%) funds (activity started in the US in the late 70s) EUROPE (15%) 3 III. CO-INVESTMENTS - VENTURE, GROWTH & BUY-OUT INVESTMENT PHILOSOPHY VENTURE & GROWTH COMPANIES MAIN PARTNERS Minority investor ($ 15-50 M equity tickets) Round led by a trusted partner F&B Focus on high-growth sectors (incl.
  • Fidelity® International Index Fund

    Fidelity® International Index Fund

    Quarterly Holdings Report for Fidelity® International Index Fund November 30, 2020 SPI-QTLY-0121 1.810719.116 Schedule of Investments November 30, 2020 (Unaudited) Showing Percentage of Net Assets Common Stocks – 97.1% Shares Value Shares Value Australia – 6.6% Washington H. Soul Pattinson & Co. Ltd. 203,862 $ 4,345,688 Afterpay Ltd. (a) 409,961 $ 28,591,537 Wesfarmers Ltd. 2,182,329 79,215,864 AGL Energy Ltd. 1,210,067 11,991,371 Westpac Banking Corp. 6,949,073 101,905,324 AMP Ltd. 6,559,158 8,233,222 WiseTech Global Ltd. 279,599 6,341,905 Ampol Ltd. 474,005 10,664,464 Woodside Petroleum Ltd. 1,845,417 30,303,036 APA Group unit 2,255,752 17,137,890 Woolworths Group Ltd. 2,432,680 66,035,510 Aristocrat Leisure Ltd. 1,100,616 25,901,504 ASX Ltd. 370,987 20,998,827 TOTAL AUSTRALIA 1,959,645,611 Aurizon Holdings Ltd. 3,707,573 11,566,562 Australia & New Zealand Banking Group Ltd. 5,458,203 90,709,286 Austria – 0.2% BHP Billiton Ltd. 5,669,746 158,108,139 Erste Group Bank AG 533,942 15,320,260 BlueScope Steel Ltd. 965,128 12,114,533 OMV AG 280,917 9,406,520 Brambles Ltd. 2,908,146 23,396,581 Raiffeisen International Bank‑Holding AG 278,553 5,314,896 Cimic Group Ltd. (a) 184,902 3,470,547 Verbund AG 130,252 9,154,254 Coca‑Cola Amatil Ltd. 972,096 9,026,623 Voestalpine AG 221,319 7,089,483 Cochlear Ltd.
  • 2020 Annual Report

    2020 Annual Report

    DECEMBER 31, 2020 2020 Annual Report BlackRock Funds III • iShares MSCI Total International Index Fund Not FDIC Insured • May Lose Value • No Bank Guarantee The Markets in Review Dear Shareholder, The 12-month reporting period as of December 31, 2020 has been a time of sudden change in global financial markets, as the emergence and spread of the coronavirus (or “COVID-19”) led to a vast disruption in the global economy and financial markets. The threat from the coronavirus became increasingly apparent throughout February and March 2020, and countries around the world took economically disruptive countermeasures. Stay-at-home orders and closures of non-essential businesses became widespread, many workers were laid off, and unemployment claims spiked, causing a global recession and a sharp fall in equity prices. After markets hit their lowest point of the reporting period in late March 2020, a steady recovery ensued, as businesses began to re-open and governments learned to adapt to life with the virus. Equity prices continued Rob Kapito to rise throughout the summer, fed by strong fiscal and monetary support and improving economic indicators. President, BlackRock Advisors, LLC Many equity indices neared or surpassed all-time highs late in the reporting period following a series of successful vaccine trials and passage of additional stimulus. In the United States, both large- and small- capitalization stocks posted a significant advance. International equities from developed economies grew at a more modest pace, lagging emerging market stocks, which rebounded sharply. Total Returns as of December 31, 2020 6-Month 12-Month During the market downturn, the performance of different types of fixed-income securities initially diverged due U.S.
  • FACTSHEET - AS of 24-Sep-2021 Solactive GBS Belgium Large & Mid Cap Index TR

    FACTSHEET - AS of 24-Sep-2021 Solactive GBS Belgium Large & Mid Cap Index TR

    FACTSHEET - AS OF 24-Sep-2021 Solactive GBS Belgium Large & Mid Cap Index TR DESCRIPTION The Solactive GBS Belgium Large & Mid Cap Index TR is part of the Solactive Global Benchmark Series which includes benchmark indices for developed and emerging market countries. The index intends to track the performance of the large and mid cap segment covering approximately the largest 85% of the free-float market capitalization in the Belgian market. It is calculated as a total return indexinEUR and weighted by free-float market capitalization. HISTORICAL PERFORMANCE 1,000 900 800 700 600 500 400 300 200 Jan-2008 Jan-2010 Jan-2012 Jan-2014 Jan-2016 Jan-2018 Jan-2020 Jan-2022 Solactive GBS Belgium Large & Mid Cap Index TR CHARACTERISTICS ISIN / WKN DE000SLA4DC5 / SLA4DC Base Value / Base Date 725.02 Points / 08.05.2006 Bloomberg / Reuters / .SBELMCT Last Price 831.43 Index Calculator Solactive AG Dividends Reinvested Index Type Total Return Calculation 8:00 am to 10:30 pm (CET), every 15 seconds Index Currency EUR History Available daily back to 08.05.2006 Index Members 16 FACTSHEET - AS OF 24-Sep-2021 Solactive GBS Belgium Large & Mid Cap Index TR STATISTICS 30D 90D 180D 360D YTD Since Inception Performance -3.37% -5.85% 5.20% 20.82% 6.01% 14.68% Performance (p.a.) - - - - - 0.89% Volatility (p.a.) 11.25% 13.27% 12.79% 17.52% 14.21% 22.53% High 863.93 878.49 901.39 901.39 901.39 1007.16 Low 813.25 813.25 797.43 650.18 749.91 203.19 Sharpe Ratio -2.98 -1.59 0.89 1.24 0.62 0.06 Max.
  • Purpose & Patience

    Purpose & Patience

    Purpose & Patience We aspire to be the preferred partners of entrepreneurs and families who lead growing companies by backing them with patient capital and supportive advice. — H1 2019 Edition — 1 1 Our mission Our goal at Sofina is to create economic value with a human face. We believe that the entrepreneurial spirit that characterises many family businesses and growth companies is a source of progress. By supporting these entrepreneurs and innovators, we intend to contribute to global growth, development and innovation. We believe entrepreneurs become successful by being competitive in a globalized market. Our mission is to provide patient capital, expertise and advice to growing companies led by entrepreneurs and families and aspire to be their preferred partner, coupled with a long-term horizon that few other investors can match. Our heritage and culture are what makes us unique. We put human relationships at the heart of what we do. All our investments are stories of shared values, friendships and ambitious projects with talented entrepreneurs and their management teams. By continuously working this way, we aspire to become the preferred investment partner for all those who share our beliefs and vision. 2 | Sofina | Purpose & Patience 3 | Our mission Highlights 2 ~€ 5 bn Global reach net6. asset value6 * A family run 3 US Europe Asia and controlled complementary investment Change over the last 20 years (1) investment company pillars 6.56 6.75 6.00 5.25 4.50 Four focus sectors 3.75 Long-term minority 3.00 1.70 investments 2.25 1.50 Offices in % NAV * 0.75 46 0 Brussels, Luxembourg Consumer 1997 2H2018 and Singapore Investments in venture and growth capital funds Digital 30% NAV * Roots going back ~ 5 Education Sofina Growth ─ 2 Investments in fast-growing investment businesses professionals * 120 Healthcare 17% NAV years across our 3 offices (1) Shareholders’ equity is net asset value as from 2017.